ABATACEPT: A NEW CHOICE FOR CHILDREN WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
<strong><em></em></strong><em>Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disorder in children. Children with polyarticular curse JIA, who do not respond to non-steroidal anti-inflammatory drugs and steroid injections, are treated with disea...
Main Author: | N. Ruperto |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2010-01-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/602 |
Similar Items
-
ABATACEPT: A NEW CHOICE FOR CHILDREN WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
by: N. Ruperto
Published: (2010-03-01) -
EFFICACY OF ABATACEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS REFRACTORY TO TNF-α
by: Yu. M. Spivakovskii, et al.
Published: (2015-04-01) -
EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01) -
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
by: Ryoki Hara, et al.
Published: (2019-04-01) -
Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
by: Hermine I. Brunner, et al.
Published: (2020-02-01)